Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,810,136
+$4,961,406 QoQ
Shares Held
85,415
+74.4% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 334 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. LQDA ranks #21 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in LQDA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,810,136 | 85,415 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,848,730 | 48,986 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $481,686 | 13,966 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $290,593 | 12,779 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $183,423 | 14,721 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $244,259 | 16,560 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $240,643 | 20,463 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $215,970 | 21,597 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $285,084 | 23,757 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $384,090 | 26,040 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $374,710 | 31,148 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $206,569 | 32,582 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $258,414 | 32,919 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $237,303 | 34,342 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $235,951 | 37,041 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $225,515 | 41,455 | Shares | Defined | 2022-11-14 | |
| 2020-12-31 | $267,862 | 90,801 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $90,621 | 18,419 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||